Chemical Structure : Asciminib
CAS No.: 1492952-76-7
Catalog No.: PC-62147Not For Human Use, Lab Use Only.
Asciminib (ABL001) is a potent and selective allosteric ABL1 inhibitor with IC50 of 0.25 nM in BCR-ABL1-transformed BaF3 cells.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $98 | In stock | |
25 mg | $158 | In stock | |
50 mg | $258 | In stock | |
100 mg | $398 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Asciminib (ABL001) is a potent and selective allosteric ABL1 inhibitor with IC50 of 0.25 nM in BCR-ABL1-transformed BaF3 cells.
Asciminib (ABL-001) binds (Kd=0.5-0.8 nM) to the myristoyl pocket of ABL1 and induces the formation of an inactive kinase conformation.
Asciminib (ABL-001) inhibits phosphorylation of both STAT5 (Tyr694; pSTAT5) and BCR–ABL1 (Tyr245; pBCR–ABL1), and shows selective activity against all BCR–ABL1 cell lines (IC50=1-20 nM).
Asciminib (ABL-001) retains activity against mutated ABL-1 Thr315Ile at low nanomolar concentrations.
Asciminib (ABL-001) is active in vivo, moderate oral absorption.
M.Wt | 449.843 | |
Formula | C20H18ClF2N5O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(R)-N-(4-(chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide |
1. Wylie AA, et al. Nature. 2017 Mar 30;543(7647):733-737.
2. Lee BJ, et al. Leukemia. 2017 May;31(5):1096-1107.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright